News Releases

Three State and Federal Grants Fund Campaign to Encourage COVID-19 Vaccination Among People with Intellectual and Developmental Disabilities
Propelled by a Pandemic, Incoming Einstein Students Begin Medical Education Journey
Einstein Students Win AΩA Leadership Award to Educate Peers and Patients about Vaccines

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Global Initiatives
Clinical and Research Centers

Expert List for Media

John S. Condeelis

John S. Condeelis, Ph.D.

Area(s) of expertise: Biomedical technologiesIntravital imagingTumor microenvironment

Dr. Condeelis is a pioneer in developing microscope techniques for use in “intravital imaging” – observing the behavior of cells in living animals. His work has led to a clinical test of biopsy… Learn more

Einstein in the News

9/11 First Responders Face Higher Cancer Risk 20 Years Later

Charles Hall, Ph.D., comments on his research that found first responders to the World Trade Center site on 9/11 have increased risk of certain cancers, including prostate cancer, which has been detected earlier than expected. Dr. Hall is professor of epidemiology & population health and in the Saul R. Korey Department of Neurology at Einstein.

Additional coverage includes: Yahoo News and MedPage Today (login required)

More coverage on Dr. Hall

Scientific American
Health Effects of 9/11 Still Plague Responders and Survivors

Rachel Zeig-Owens, Dr.P.H., discusses her research on FDNY first responders to the 9/11 terrorist attack, including findings that those who arrived at the World Trade Center site earliest have the highest rates of respiratory disease. Dr. Zeig-Owens is assistant professor of epidemiology & population health at Einstein and director of epidemiology and the lead epidemiologist for the World Trade Center Health Program at the Fire Department of the City of New York.

Additional Coverage includes The Scientist, NPR

Kids and COVID: Why Young Immune Systems are Still on Top

Betsy Herold, M.D. comments on her study that found children mount a stronger innate immune response to COVID-19 compared to adults, which helps them eliminate the virus' threat. Dr. Herold is chief of infectious diseases and vice chair for research in the department of pediatrics at Einstein and Children's Hospital at Montefiore and the Harold and Muriel Block Chair in Pediatrics at Einstein.

More coverage on Dr. Herold


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog